BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

401 related articles for article (PubMed ID: 9853256)

  • 21. Association of calnexin with wild type and mutant AVPR2 that causes nephrogenic diabetes insipidus.
    Morello JP; Salahpour A; Petäjä-Repo UE; Laperrière A; Lonergan M; Arthus MF; Nabi IR; Bichet DG; Bouvier M
    Biochemistry; 2001 Jun; 40(23):6766-75. PubMed ID: 11389590
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vasopressin receptor mutations causing nephrogenic diabetes insipidus.
    Bichet DG; Turner M; Morin D
    Proc Assoc Am Physicians; 1998; 110(5):387-94. PubMed ID: 9756088
    [TBL] [Abstract][Full Text] [Related]  

  • 23. V2 vasopressin receptor dysfunction in nephrogenic diabetes insipidus caused by different molecular mechanisms.
    Schöneberg T; Schulz A; Biebermann H; Grüters A; Grimm T; Hübschmann K; Filler G; Gudermann T; Schultz G
    Hum Mutat; 1998; 12(3):196-205. PubMed ID: 9711877
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A Novel Mutation in the
    Çelebi Tayfur A; Karaduman T; Özcan Türkmen M; Şahin D; Çaltık Yılmaz A; Büyükkaragöz B; Buluş AD; Mergen H
    J Clin Res Pediatr Endocrinol; 2018 Nov; 10(4):350-356. PubMed ID: 29991464
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Partial nephrogenic diabetes insipidus caused by a novel mutation in the AVPR2 gene.
    Faerch M; Christensen JH; Corydon TJ; Kamperis K; de Zegher F; Gregersen N; Robertson GL; Rittig S
    Clin Endocrinol (Oxf); 2008 Mar; 68(3):395-403. PubMed ID: 17941907
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nephrogenic diabetes insipidus.
    Morello JP; Bichet DG
    Annu Rev Physiol; 2001; 63():607-30. PubMed ID: 11181969
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Six novel mutations in the vasopressin V2 receptor gene causing nephrogenic diabetes insipidus.
    Cheong HI; Park HW; Ha IS; Moon HN; Choi Y; Ko KW; Jun JK
    Nephron; 1997; 75(4):431-7. PubMed ID: 9127330
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Novel AVPR2 mutation causing partial nephrogenic diabetes insipidus in a Japanese family.
    Yamashita S; Hata A; Usui T; Oda H; Hijikata A; Shirai T; Kaneko N; Hata D
    J Pediatr Endocrinol Metab; 2016 May; 29(5):591-6. PubMed ID: 26974133
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical phenotype of nephrogenic diabetes insipidus in females heterozygous for a vasopressin type 2 receptor mutation.
    van Lieburg AF; Verdijk MA; Schoute F; Ligtenberg MJ; van Oost BA; Waldhauser F; Dobner M; Monnens LA; Knoers NV
    Hum Genet; 1995 Jul; 96(1):70-8. PubMed ID: 7607658
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular genetic study of congenital nephrogenic diabetes insipidus and rescue of mutant vasopressin V2 receptor by chemical chaperones.
    Cheong HI; Cho HY; Park HW; Ha IS; Choi Y
    Nephrology (Carlton); 2007 Apr; 12(2):113-7. PubMed ID: 17371330
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diverse vasopressin V2 receptor functionality underlying partial congenital nephrogenic diabetes insipidus.
    Faerch M; Christensen JH; Rittig S; Johansson JO; Gregersen N; de Zegher F; Corydon TJ
    Am J Physiol Renal Physiol; 2009 Dec; 297(6):F1518-25. PubMed ID: 19812297
    [TBL] [Abstract][Full Text] [Related]  

  • 32. C112R, W323S, N317K mutations in the vasopressin V2 receptor gene in patients with nephrogenic diabetes insipidus. Mutations in brief no. 165. Online.
    Szalai C; Triga D; Czinner A
    Hum Mutat; 1998; 12(2):137-8. PubMed ID: 10694923
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intrafamilial phenotype variability in nephrogenic diabetes insipidus.
    Kalenga K; Persu A; Goffin E; Lavenne-Pardonge E; van Cangh PJ; Bichet DG; Devuyst O
    Am J Kidney Dis; 2002 Apr; 39(4):737-43. PubMed ID: 11920339
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hereditary Nephrogenic Diabetes Insipidus: Pathophysiology and Possible Treatment. An Update.
    Milano S; Carmosino M; Gerbino A; Svelto M; Procino G
    Int J Mol Sci; 2017 Nov; 18(11):. PubMed ID: 29125546
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mutations in the vasopressin V2 receptor gene in families with nephrogenic diabetes insipidus and functional expression of the Q-2 mutant.
    Rosenthal W; Seibold A; Antaramian A; Gilbert S; Birnbaumer M; Bichet DG; Arthus MF; Lonergan M
    Cell Mol Biol (Noisy-le-grand); 1994 May; 40(3):429-36. PubMed ID: 7920187
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inheritance of mutations in the V2 receptor gene in thirteen families with nephrogenic diabetes insipidus.
    Knoers NV; van den Ouweland AM; Verdijk M; Monnens LA; van Oost BA
    Kidney Int; 1994 Jul; 46(1):170-6. PubMed ID: 7933835
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cell biological aspects of the vasopressin type-2 receptor and aquaporin 2 water channel in nephrogenic diabetes insipidus.
    Robben JH; Knoers NV; Deen PM
    Am J Physiol Renal Physiol; 2006 Aug; 291(2):F257-70. PubMed ID: 16825342
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression studies of two vasopressin V2 receptor gene mutations, R202C and 804insG, in nephrogenic diabetes insipidus.
    Tsukaguchi H; Matsubara H; Inada M
    Kidney Int; 1995 Aug; 48(2):554-62. PubMed ID: 7564126
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Deletion of the V2 vasopressin receptor gene in two Chinese patients with nephrogenic diabetes insipidus.
    Dong Y; Sheng H; Chen X; Yin J; Su Q
    BMC Genet; 2006 Nov; 7():53. PubMed ID: 17101063
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A large deletion of the AVPR2 gene causing severe nephrogenic diabetes insipidus in a Turkish family.
    Saglar E; Deniz F; Erdem B; Karaduman T; Yönem A; Cagiltay E; Mergen H
    Endocrine; 2014 May; 46(1):148-53. PubMed ID: 24026507
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.